Cloned (Comment) | Organism |
---|---|
expression of wild-type and mutant enzymes in Escherichia coli strain BL21(DE3) | Human immunodeficiency virus 1 |
Protein Variants | Comment | Organism |
---|---|---|
E89K | site-directed mutagenesis, foscarnet-resistance mutation, the mutant enzyme shows different sensitivity for inhibitors compared to the wild-type enzyme, overview | Human immunodeficiency virus 1 |
K103N | site-directed mutagenesis, NNRTI-resistance mutation, the mutant enzyme shows different sensitivity for inhibitors compared to the wild-type enzyme, overview | Human immunodeficiency virus 1 |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
4-(1-chloro-1,1-difluoromethyl)-4-(2-phenylethynyl)-6-chloro-2H-3,1-benzoxazin-2-one | i.e. NNRTI, an efavirenz analogue, IC50 values for wild-type enzyme are 0.000002-0.000005 mM with substrates DNA-17-nucleotide-RNA hybrid or DNA-18-nucleotide-RNA hybrid, and 0.001 mm for substrate DNA-15-nucleotide-RNA hybrid or DNA-16-nucleotide-RNA hybrid, effect on mutant enzymes, overview | Human immunodeficiency virus 1 | |
4-[5-(benzoylamino)thien-2-yl]-2,4-dioxobutanoic acid | a diketo acid RNase H inhibitor, IC50 values for wild-type and mutant enzymes are 0.002-0.0035 mM with all substrates, effect on mutant enzymes, overview | Human immunodeficiency virus 1 | |
additional information | effects of reverse transcriptase polymerase domain inhibitors on RNase H activity dependent on the substrate, overview, no inhibition of RNase H by nucleoside analogue 3'-azido-3'-deoxythymidine triphosphate | Human immunodeficiency virus 1 | |
Phosphonoformate | the inhibitor that bind in the reverse transcriptase polymerase domain inhibits also RNase H activity, IC value for the wild-type enzyme is 0.0015 mM versus substrate DNA-18-nucleotide-RNA hybrid, with the other substrates the IC50 value is above 0.025 mM | Human immunodeficiency virus 1 |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
additional information | - |
additional information | kinetics | Human immunodeficiency virus 1 | |
0.000007 | - |
DNA-17-nucleotide-RNA hybrid | pH 7.8, 37°C, recombinant wild-type enzyme | Human immunodeficiency virus 1 | |
0.000011 | - |
DNA-18-nucleotide-RNA hybrid | pH 7.8, 37°C, recombinant wild-type enzyme | Human immunodeficiency virus 1 | |
0.000052 | - |
DNA-16-nucleotide-RNA hybrid | pH 7.8, 37°C, recombinant wild-type enzyme | Human immunodeficiency virus 1 | |
0.000053 | - |
DNA-15-nucleotide-RNA hybrid | pH 7.8, 37°C, recombinant wild-type enzyme | Human immunodeficiency virus 1 |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
KCl | activates | Human immunodeficiency virus 1 | |
Mg2+ | activates | Human immunodeficiency virus 1 |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Human immunodeficiency virus 1 | - |
i.e. HIV-1 | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
additional information | - |
- |
Human immunodeficiency virus 1 |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
DNA-15-nucleotide-RNA hybrid + H2O | - |
Human immunodeficiency virus 1 | ? | - |
? | |
DNA-16-nucleotide-RNA hybrid + H2O | - |
Human immunodeficiency virus 1 | ? | - |
? | |
DNA-17-nucleotide-RNA hybrid + H2O | - |
Human immunodeficiency virus 1 | ? | - |
? | |
DNA-18-nucleotide-RNA hybrid + H2O | - |
Human immunodeficiency virus 1 | ? | - |
? | |
DNA-RNA hybrid + H2O | fluorescent-labeled RNA-DNA duplex of 15, 16, 17, or 18 nucleotide-RNA and in each case 18 nucleotide-DNA, overview | Human immunodeficiency virus 1 | ? | - |
? | |
additional information | the enzyme is part of the viral reverse transcriptase residing on distinct domains of the enzyme with the DNA polymerase activity | Human immunodeficiency virus 1 | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
More | the enzyme is part of the viral reverse transcriptase | Human immunodeficiency virus 1 |
ribonuclease H | - |
Human immunodeficiency virus 1 |
RNase H | - |
Human immunodeficiency virus 1 |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Human immunodeficiency virus 1 |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0018 | - |
DNA-17-nucleotide-RNA hybrid | pH 7.8, 37°C, recombinant wild-type enzyme | Human immunodeficiency virus 1 | |
0.0032 | - |
DNA-18-nucleotide-RNA hybrid | pH 7.8, 37°C, recombinant wild-type enzyme | Human immunodeficiency virus 1 | |
0.0135 | - |
DNA-15-nucleotide-RNA hybrid | pH 7.8, 37°C, recombinant wild-type enzyme | Human immunodeficiency virus 1 | |
0.017 | - |
DNA-16-nucleotide-RNA hybrid | pH 7.8, 37°C, recombinant wild-type enzyme | Human immunodeficiency virus 1 |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.8 | - |
assay at | Human immunodeficiency virus 1 |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
additional information | - |
additional information | inhibition kinetics | Human immunodeficiency virus 1 |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.00002 | 0.00005 | i.e. NNRTI, an efavirenz analogue, IC50 values for wild-type enzyme are 0.00002-0.00005 mM with substrates DNA-17-nucleotide-RNA hybrid or DNA-18-nucleotide-RNA hybrid | Human immunodeficiency virus 1 | 4-(1-chloro-1,1-difluoromethyl)-4-(2-phenylethynyl)-6-chloro-2H-3,1-benzoxazin-2-one | |
0.001 | - |
0.001 mM for substrate DNA-15-nucleotide-RNA hybrid or DNA-16-nucleotide-RNA hyb | Human immunodeficiency virus 1 | 4-(1-chloro-1,1-difluoromethyl)-4-(2-phenylethynyl)-6-chloro-2H-3,1-benzoxazin-2-one | |
0.002 | 0.0035 | a diketo acid RNase H inhibitor, IC50 values for wild-type and mutant enzymes are 0.002-0.0035 mM with all substrates, effect on mutant enzymes, overview | Human immunodeficiency virus 1 | 4-[5-(benzoylamino)thien-2-yl]-2,4-dioxobutanoic acid | |
0.025 | - |
the inhibitor that bind in the reverse transcriptase polymerase domain inhibits also RNase H activity, IC value for the wild-type enzyme is 0.0015 mM versus substrate DNA-18-nucleotide-RNA hybrid, with the other substrates the IC50 value is above 0.025 mM | Human immunodeficiency virus 1 | Phosphonoformate |